A detailed history of Avion Wealth transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Avion Wealth holds 140 shares of ADPT stock, worth $831. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140
Previous 140 -0.0%
Holding current value
$831
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$2.34 - $3.96 $2 - $3
1 Added 0.72%
140 $0
Q1 2024

May 03, 2024

BUY
$2.88 - $4.8 $69 - $115
24 Added 20.87%
139 $1,000
Q4 2023

Jan 26, 2024

BUY
$3.46 - $5.33 $397 - $612
115 New
115 $1,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.